Author: Matthew Nelson|| Date Published: December 16, 2019
McKesson (NYSE: MCK) has received a potential eight-year contract of undisclosed value to provide pharmaceutical supplies to outpatient clinics, medical centers and the Department of Veterans Affairs™ consolidated mail outpatient pharmacies.
Efforts under the contract are intended to support over 750 sites and seven CMOPs operated by the VA, the companysaid Thursday.
Contract work has a base period of two years starting in August and could extend to six more years if all options are exercised.
œWe are honored to once again be selected for the important responsibility of serving those who serve us and providing quality care for our veterans, said Brian Tyler, CEO at McKesson.
The Space Development Agency has awarded $3.5 billion in other transaction authority agreements to Lockheed Martin, L3Harris Technologies, Northrop Grumman…
The Defense Health Agency has awarded TriWest Healthcare Alliance $6.8 billion to continue providing healthcare and administrative services in support…
